A Double Blind Trial of Pembrolizumab Plus Enzalutamide vs Placebo Plus Enzalutamide In Patients with Metastatic Castration-Resistant Prostate Cancer (MK3475-641)
A Double Blind Trial of Pembrolizumab Plus Enzalutamide vs Placebo Plus Enzalutamide In Patients with Metastatic Castration-Resistant Prostate Cancer (MK3475-641)
Trial Category:
Genitourinary
Phase
III
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
